Accession Number : ADA306186

Title :   Special Sabbatical for Training in Health Decision Sciences with Application to Breast Cancer Treatment Evaluation.

Descriptive Note : Final rept. 1 Feb 95-31 Jan 96,

Corporate Author : DANA-FARBER CANCER INST BOSTON MA

Personal Author(s) : Gelber, Richard D.

PDF Url : ADA306186

Report Date : FEB 1996

Pagination or Media Count : 75

Abstract : A special sabbatical year enabled Dr. Richard D. Gelber, Ph.D., an internationally respected clinical trial biostatistician, to receive training in contemporary methods and applications of health decision sciences. Dr. Gelber has been the Director of the Statistical and Data Management Center for the International Breast Cancer Study Group (IBCSG: formerly Ludwig Group) since 1978. With Dr. Aron Goldhirsch, IBCSG Scientific Director, he developed the Q-TWiST method (Quality-adjusted Time Without Symptoms of disease and Toxicity of treatment) for integrating aspects of quality of life into an evaluation of adjuvant therapies for operable breast cancer. Dr. Gelber also participates in the Worldwide Overview of randomized clinical trials evaluating adjuvant therapies for breast cancer. In addition, he currently coordinates biostatistics for the Division of Pediatrics at Dana-Farber Cancer Institute, directs the Pediatric Section of the Statistics and Data Analysis Center for the NIH AIDS Clinical Trials Group, and teaches a course in clinical trials at the Harvard School of Public Health. This award freed Dr. Gelber from his non-breast cancer related research responsibilities for one year, and enabled him to study methods in health decision sciences under the mentorship of Professor Milton Weinstein. This significantly enhanced Dr. Gelber's ability to influence treatment choices for patients with breast cancer by refining interpretation of clinical trial results. The special sabbatical coincided with the third update of the Worldwide Overview in which Dr. Gelber participated.

Descriptors :   *TEST AND EVALUATION, *DECISION MAKING, *COST EFFECTIVENESS, *CLINICAL MEDICINE, *DISEASES, *ADMINISTRATIVE PERSONNEL, *MAMMARY GLANDS, *BREAST CANCER, DATA PROCESSING, LEADERSHIP, MANAGEMENT, DATA MANAGEMENT, SCHOOLS, HEALTH, TOXICITY, RANDOM VARIABLES, STATISTICS, SIGNS AND SYMPTOMS, COORDINATES, INFORMATION CENTERS, PUBLIC HEALTH, PHARMACOLOGY, ACQUIRED IMMUNE DEFICIENCY SYNDROME, CANCER, PEDIATRICS, LIVING STANDARDS, SCIENTISTS, BIOSTATISTICS.

Subject Categories : Medicine and Medical Research
      Personnel Management and Labor Relations
      Anatomy and Physiology
      Operations Research

Distribution Statement : APPROVED FOR PUBLIC RELEASE